News

Regeneron's weight-loss drug combo helps preserve muscle in study
Regeneron Pharmaceuticals said on Monday a combination of its experimental drug and Novo Nordisk's obesity drug Wegovy helped ...
Ozempic Without Muscle Loss? New Drug Combo Trial Finds It’s Possible
By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...
UNILAD8d
Wegovy study labeled medical breakthrough in fighting key side effect of weight loss medication
Regeneron's trevogrumab trial has proved, overall, successful - potentially providing a solution to a reported Wegovy side ...
Fierce Biotech10d
Regeneron pens $2B pact for Hansoh's potential obesity rival to Lilly's Zepbound
Regeneron isn’t the only Big Pharma to spot potential in Hansoh’s obesity pipeline. Merck & Co. ended last year paying $112 ...
PharmExec8d
Regeneron’s Semaglutide Plus Trevogrumab Combo Demonstrates Superior Fat Loss with Reduced Muscle Wasting in Obesity Trial
Interim results from the Phase II COURAGE trial show that combining semaglutide with anti-GDF8 antibody trevogrumab preserves ...
Regeneron Pharmaceuticals, Inc. (REGN)’s Weight-Loss Drug Aids Muscle Preservation in Wegovy Users
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced on Monday that its experimental drug, when combined with Novo ...
Weight-loss drugs’ impact on cancer risk revealed in new study
Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 ...
New York Post29d
This drug led to 50% more weight loss than Wegovy in head-to-head study
Deciding which jab to nab? When it comes to shedding pounds and cinching inches, a new study puts one weight loss drug ahead of another. Published in the New England Journal of Medicine ...
PMLive8d
Regeneron gains rights to Hansoh’s GLP-1/GIP receptor agonist in deal worth $2bn
Regeneron Pharmaceuticals has announced that it will be gaining rights to Hansoh Pharmaceuticals’ investigational dual ...